Neurodiagnostics Market Size, Share & Trends Analysis Report By Technology (Neuroimaging Technologies, In Vitro Diagnostics, Neuroinformatics), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024

Description

Neurodiagnostics Market Growth & Trends:

The global neurodiagnostics market size is expected to reach USD 22.99 billion by 2030 ,registering a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Key factors driving the market growth include increasing prevalence of neurological diseases due to demographic changes and growing awareness of their management. In addition, consistent technological modifications coupled with increased preference for novel diagnostic technologies will further fuel the market. The economic burden of neurological diseases is extremely high on society and governments with around 1 billion people suffering globally.

Among all the neuroimaging techniques, computed tomography has the largest market share followed by Magnetic Resonance Imaging (MRI). Computed Tomography (CT) uses ionized radiations for the purpose of creating images, whereas MRI uses radio waves in a magnetic field. Neuroimaging techniques are used to detect brain injuries, developmental malformations in the brain area, vascular irregularities that may lead to stroke, epilepsy, etc.

Biomarkers are an important part of in vitro diagnostics for neurological disorders as their development is targeted at the early disease diagnosis with information about the nervous system. Although biomarkers are not commercially available in the market, their use is confined to clinical research settings. For instance, ELISA tests for Tau protein are available in clinical studies of Alzheimer's disease. In addition, neuroinformatics is a field that studies neuroscience and information technology. This integration allows the storage of neurological data in the form of databases. The neuroinformatics market is expected to grow at the second-highest growth rate during the forecast period.

Neurodiagnostics Market Report Highlights:

Increased life expectancy has resulted in an increased geriatric population across the globe. The prevalence of aging-related neurological diseases such as Alzheimer's disease and Parkinson's disease is on the rise. The diagnosis of these diseases includes neuroimaging, in vitro diagnosis, and neuroinformatics.
CT and MRI are the most commonly used imaging techniques across the globe, which are mainly used to detect brain abnormalities.
Neurological biomarkers are extremely promising as they provide a direction to the diagnostic studies. Although currently, no commercial biomarker is available in the market, extensive clinical research is happening to find out the perfect combinations of the biomarkers.
North America held the major market share of around 35.8% in 2023 and will retain its top position during the forecast period. On the other hand, Asia Pacific will exhibit the highest CAGR of 4.5% over the forecast period.

Product Code: GVR-1-68038-277-8

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Neurodiagnostics Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Neurodiagnostics Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Neurodiagnostics Market: Technology Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Neurodiagnostics Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
4.3. Neuroimaging Technologies
- 4.3.1. Neuroimaging Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Computed Tomography (CT)
  - 4.3.2.1. Computed Tomography (CT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Magnetic Resonance Imaging (MRI)
  - 4.3.3.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.4. Nuclear Medicine Imaging (PET, SPECT)
  - 4.3.4.1. Nuclear Medicine Imaging (PET, SPECT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.5. Near infrared spectroscopic imaging (NIRS)
  - 4.3.5.1. Near infrared spectroscopic imaging (NIRS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.6. Electro-encephalography (EEG)
  - 4.3.6.1. Electro-encephalography (EEG) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.7. Magneto-encephalography (MEG)
  - 4.3.7.1. Magneto-encephalography (MEG) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.8. Voxel based morphometry (VBM)
  - 4.3.8.1. Voxel based morphometry (VBM) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. In Vitro Diagnostics
- 4.4.1. In Vitro Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Neuroinformatics
- 4.5.1. Neuroinformatics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurodiagnostics Market: End Use Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Neurodiagnostics Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
5.3. Hospitals and Clinics
- 5.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Diagnostic Laboratories
- 5.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Imaging Centers Market
- 5.5.1. Imaging Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
- 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurodiagnostics Market: Regional Estimates & Trend Analysis

6.1. Neurodiagnostics Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
- 6.2.1. North America Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. U.S.
  - 6.2.2.1. U.S. Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Canada
  - 6.2.3.1. Canada Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Mexico
  - 6.2.4.1. Mexico Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
- 6.3.1. Europe Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. UK
  - 6.3.2.1. UK Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Germany
  - 6.3.3.1. Germany Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. France
  - 6.3.4.1. France Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Italy
  - 6.3.5.1. Italy Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.6. Spain
  - 6.3.6.1. Spain Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.7. Denmark
  - 6.3.7.1. Denmark Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.8. Sweden
  - 6.3.8.1. Sweden Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.9. Norway
  - 6.3.9.1. Norway Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
- 6.4.1. Asia Pacific Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2. China
  - 6.4.2.1. China Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. Japan
  - 6.4.3.1. Japan Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. India
  - 6.4.4.1. India Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.5. South Korea
  - 6.4.5.1. South Korea Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.6. Australia
  - 6.4.6.1. Australia Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.7. Thailand
  - 6.4.7.1. Thailand Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
- 6.5.1. Latin America Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
  - 6.5.2.1. Brazil Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Argentina
  - 6.5.3.1. Argentina Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. Saudi Arabia
  - 6.6.2.1. Saudi Arabia Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. UAE
  - 6.6.3.1. UAE Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. South Africa
  - 6.6.4.1. South Africa Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. Kuwait
  - 6.6.5.1. Kuwait Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
- 7.4.1. Canon Medical Systems Corporation
  - 7.4.1.1. Participant's Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Product Benchmarking
  - 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. Siemens Healthineers AG
  - 7.4.2.1. Participant's Overview
  - 7.4.2.2. Financial Performance
  - 7.4.2.3. Product Benchmarking
  - 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Koninklijke Philips N.V.
  - 7.4.3.1. Participant's Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Product Benchmarking
  - 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. Thermo Fisher Scientific, Inc.
  - 7.4.4.1. Participant's Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Product Benchmarking
  - 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. FUJIFILM Corporation
  - 7.4.5.1. Participant's Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Product Benchmarking
  - 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. Natus Medical Incorporated (Natus)
  - 7.4.6.1. Participant's Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Product Benchmarking
  - 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. Lifelines Neuro
  - 7.4.7.1. Participant's Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Product Benchmarking
  - 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. Advanced Brain Monitoring, Inc.
  - 7.4.8.1. Participant's Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Product Benchmarking
  - 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.9. NIHON KOHDEN CORPORATION.
  - 7.4.9.1. Participant's Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Product Benchmarking
  - 7.4.9.4. Recent Developments/ Strategic Initiatives
- 7.4.10. F. Hoffmann-La Roche Ltd
  - 7.4.10.1. Participant's Overview
  - 7.4.10.2. Financial Performance
  - 7.4.10.3. Product Benchmarking
  - 7.4.10.4. Recent Developments/ Strategic Initiatives
- 7.4.11. GE HealthCare.
  - 7.4.11.1. Participant's Overview
  - 7.4.11.2. Financial Performance
  - 7.4.11.3. Product Benchmarking
  - 7.4.11.4. Recent Developments/ Strategic Initiatives
- 7.4.12. Mitsar Co. LTD.
  - 7.4.12.1. Participant's Overview
  - 7.4.12.2. Financial Performance
  - 7.4.12.3. Product Benchmarking
  - 7.4.12.4. Recent Developments/ Strategic Initiatives

Neurodiagnostics Market Size, Share & Trends Analysis Report By Technology (Neuroimaging Technologies, In Vitro Diagnostics, Neuroinformatics), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030